tbuckley/cabot-search huggingface dataset:
Medical Education, Registration and Hospital Service
Journal: JAMA (1925)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
ILLNESS OF PROMINENT PERSONS
Journal: JAMA (1994)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Simulation in surgical training.
Journal: BMJ (1990)

renew the plasticine lining and repeat the procedure until one is confident in the mechanics of the resectoscope.We have used this model regularly at our gynaecological endoscopy workshops and the response of trainees has been universally positive.With minor modifications, urologists in training and others who use a resectoscope within a cavity may also find it a useful aid for endoscopic procedures.
Advances in cardiovascular pharmacology
Authors: A. H. Hayes
Journal: JAMA (1982)

This is an exciting era in pharmacology, and cardiovascular pharmacology provides a good example of this excitement. Substantial advances have been made in our understanding of cardiovascular physiology and in the pathophysiology of the major diseases with which we are dealing: heart failure, hypertension, and coronary artery disease. The methods of diagnosis of cardiovascular diseases and of evaluating the efficacy of pharmacologic therapy have progressed also. Better patient care and innovative cardiovascular pharmacology have evolved because of these advances. Not many years ago, if an investigator wanted to study an antiarrhythmic drug, he administered the drug to a hospitalized patient with an arrhythmia and did an ECG every half hour. Now we have coronary care units and electronic monitoring, including Holter tapes to monitor patients outside of the hospital during their daily activities. As a result, we can get better data more rapidly on the effect of new drugs. These
pharmacology
Journal: JAMA (1910)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Deaf Aids
Authors: A. H. Dodd
Journal: BMJ (1945)

Four chemical methods of deacidification investigated to reduce the acidity of wine by 0.3% were Acidex, calcium carbonate, potassium carbonate, and a 50:50 combination of the carbonates. Carbonic maceration was included for comparison. These five methods were chosen because they are reasonably easy for small wineries to use. Wine prepared by a standard vinification technique from each variety was divided into four 6-gallon lots for each of the four chemical methods. Seyve-Villard 12375 was available in limited quantities, so only the Acidex and the 50:50 combination methods were used. The sensory properties of these wines were ranked for aroma/bouquet and taste/flavor by three groups of tasters over a two-year period. Included in the evaluations for comparison were commercial French hybrid wines obtainable locally. The three groups of tasters found very few statistically significant differences among the experimental and commercial wines. Differences found by one group of tasters were not confirmed by the other two groups.
Reye's syndrome associated with long-term aspirin therapy
Authors: R. S. Young
Journal: JAMA (1984)

Reye's syndrome has been infrequently described in children receiving long-term salicylate therapy. We report the clinical and laboratory findings of two children in whom Reye's syndrome developed while taking salicylates for systemic inflammatory disorders. Monitoring of hepatocellular function should be considered in children who are receiving long-term salicylate therapy. (<i>JAMA</i>1984;251:754-756)
Potency of levothyroxine products
Authors: S. S. Stoffer
Journal: JAMA (1984)

Recently, the company that manufactures the levothyroxine product that we use most often in our practice switched to high-pressure liquid chromotography (HPLC) to monitor their product. As a result, the brand name product now contains 100% of expected potency as determined in our laboratory by radioimmunoassay. Previous studies in our laboratory demonstrated that this product had only 78% of expected potency. This year our patients have a higher mean serum free thyroxine index (FTI) than they have had in the past. In addition, there were more elevated serum FTI levels and fewer elevated serum thyroid-stimulating hormone levels this year. Physicians should be aware of possible product changes being made by manufacturers of levothyroxine products over the next year or so as more companies switch to the HPLC method. The thyroid function studies of patients receiving levothyroxine products should be rather carefully monitored during this transitional period. We suspect that the new products will be more consistent and have a more reliable shelf life. (<i>JAMA</i>1984;251:635-636)
Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa
Authors: G Fattovich
Journal: Hepatology (1997)

The aim of this study was to evaluate whether interferon alfa (IFN-α) treatment-associated virological and biochemical remission improves survival in a cohort of 90 white patients with compensated cirrhosis caused by hepatitis B (Child A) followed for a mean period of 7 years. Inclusion criteria were biopsy-proven cirrhosis, hepatitis B e antigen (HBeAg) positivity, abnormal serum aminotransferase levels, exclusion of hepatitis delta virus, and absence of complications of cirrhosis. Of the 40 IFN-treated patients, 27 (67%) showed sustained HBeAg loss with alanine aminotransferase (ALT) normalization. Of the 50 untreated patients, 30 (60%) cleared HBeAg, but only 21 (42%) normalized ALT after HBeAg loss. Compared with the untreated patients, IFN-treated patients had similar cumulative rates of HBeAg clearance (P = .48), but higher rates of ALT normalization (P = .016) and of HBsAg loss (P = .028). During follow-up, liver-related death occurred in 8 treated patients, caused by liver failure in 5 and hepatocellular carcinoma (HCC) in 3; all 8 had continued to be HBeAg-positive with elevated ALT. None of the treated patients undergoing remission developed liver-related complications. At univariate analysis, life expectancy was longer in treated patients showing sustained remission than in those who did not (5-year survival: 100% vs. 81%; P = .048). Fourteen untreated patients died (from liver failure in 10 and HCC in 4); all but 3 had continued to be HBeAg-positive with elevated ALT. Cox's model identified age and ALT normalization as the only significant predictors of survival. In conclusion, in patients with HBeAg-positive compensated cirrhosis, virological and biochemical remission following IFN therapy is associated with improved survival.
Correction: Age Interactions in the Development of Naturally Acquired Immunity to Plasmodium falciparum and Its Clinical Presentation
Authors: John J Aponte, Clara Menendez, David Schellenberg, Elizeus Kahigwa, Hassan Mshinda, Penelope Vountasou, Marcel Tanner, Pedro L Alonso
Journal: PLoS Medicine (2007)

There was an error in Figure 4A published with this paper.The information contained in the figure is accurate but corresponds to an analysis comparing the cumulative rate of clinical malaria between the groups that received iron supplementation or placebo in this trial.The correct graph of the comparison between the antimalarial chemoprophylaxis and the placebo group is shown here.
285TiP DANUBE: A Phase 3 randomised study of first-line durvalumab (MEDI4736) 6 tremelimumab vs standard of care (SoC) chemotherapy (CT) in patients (pts) with Stage IV urothelial carcinoma (UC)
Authors: S.H. Park, D. Castellano, D.P. Petrylak, M.D. Galsky, M.S. van der Heijden, Y. Loriot, O. Ogawa, W.-P. Su, W. Huang, W. Levin, S. Ferro, Y. Ben, J. Bellmunt, T. Powles
Journal: Annals of Oncology (2016)
Fifth week of Desert Storm fighting brings new challenges for medicine
Authors: P. Gunby
Journal: JAMA (1991)

AS ANTICIPATED, Desert Storm ground fighting is bringing a new set of challenges in terms of prompt evacuation and treatment of wounded allied soldiers. When Iraqi forays into Saudi Arabia brought a start to ground fighting 3 weeks ago, the situation also highlighted the importance of US military medical planning. This includes self- or buddy-care by US troops who are trained in some essential emergency medical procedures such as control of bleeding, additional procedures (such as airway clearance) by a "combat lifesaver" in the squad with additional training and equipment (<i>JAMA</i>. 1991;265:557-559), help from Advanced Trauma Life Support-certified corpsmen, and eventually attention from a physician. As also was expected, evacuation of the wounded is challenging along this flat terrain where would-be rescuers are vulnerable to enemy groundfire. Helicopters are much less likely to be used for frontline medical evacuation (than they were used, for instance, in the Southeast Asian theater
Fortification of Flour and Bread With Iron
Authors: Grace A. Goldsmith
Journal: JAMA (1973)

The AMA Council on Foods and Nutrition has followed with great interest the arguments for and against additional fortification of flour and bread with iron.<i>It is the considered judgement of the Council that increased fortification is a logical step at the present time to improve iron balance</i>. The Council appreciates, also, that factual information concerning both the beneficial and possible harmful effects of this fortification is limited and that very little research has been carried out in this area during the past two years when fortification has been under discussion. The Council strongly urges that research be expanded and that funds be appropriated to determine both the benefits of iron fortification and its potential hazards. Specific studies that are indicated include investigations of absorption of various iron salts in intact meals and with different types of diet, development of new methods to measure iron stores, including application of iron
MEDICAL FILM REVIEWS
Journal: JAMA (1960)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Cold virus spurs range of remedies
Authors: C. A. Raymond
Journal: JAMA (1986)

Radiation is just one of the latest strategies to outfox the tenacious common cold viruses. Recent surveys indicate that acute respiratory illnesses account for more than half of all acute disabling disease, with colds being the most common of such disorders (<i>National Health Survey</i>, US Dept of Health, Education, and Welfare publication No. 79-1560. 1979:3). Colds occur at the rate of 100 million disabling cases annually, causing about 250 million days of restricted activity, and 30 million days lost at work or school. Sales of over-the-counter cold remedies amount to more than $1 billion annually, and these remedies apparently are used to treat two to five colds per American each year. Schoolchildren contract as many as a dozen colds each year (Fox JP and Hall CE:<i>Viruses in Families</i>. Littleton, Mass, PSG Publishing, 1985; Murphy W:<i>Coping with the Common Cold</i>. Alexandria, Va, Time-Life Books, 1981). It is figures like
Books Received
Journal: JAMA (1989)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
COUGH
Journal: JAMA (1928)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Should children with isolated anti-HBs or anti-HBc be immunized against hepatitis B virus?
Authors: B. Duval
Journal: JAMA (1997)

<h3>To the Editor.</h3> —The desirability of universal immunization of young adolescents against hepatitis B virus (HBV) has recently been reemphasized by the National Coalition for Adult Immunization and the Centers for Disease Control and Prevention.<sup>1</sup>On occasion, HBV serology is available in an unvaccinated child scheduled for immunization. If only 1 of the HBV antibodies is positive, a decision has to be made whether this is likely to be a false-positive result. In Quebec City, approximately 7000 fourth-grade children are immunized each year in the provincial program of universal immunization. In 1995, we conducted a prevaccination seroprevalence survey in these children. All children were eligible. Parents were called sequentially to participate in the study as soon as the consent form they had to sign to have their child immunized in the provincial program was received. The required sample size of 1200 was reached after calling 2014 parents. Among those
Allgemeine und experimentelle Pathologie nach Vorlesungen für Studierende und Aerzte.
Journal: JAMA (1927)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Hypertension Reference
Journal: JAMA (1977)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Galen: [A Bibliographical Demonstration in the Library of the Faculty of Physicians and Surgeons of Glasgow, December 9th, 1891.]
Authors: J. Finlayson
Journal: BMJ (1892)

AT our last bibliographical demonstration I showed you, in the various editions we possess in this library, the works of Hippocrates2, who is often styled the " Father of Medicine."To-night we have on the table before us the works of Galen, who is sometimes termed the "Prince of Physicians."His name is given in various languages as rAAHNOI, Galenus, Gialen, Galien.The chronology, or dates of his life, unlike those of Hippocrates, are not involved in any great doubt, for in his own writings there are very numerous autobiographical and historical details,3 which allow of considerable accuracy in tracing his course.As mere dates afford to many of us but slight indications of the period when a man flourished T give here certain dates as landmarks to guide
Cephalhematoma complicated by osteomyelitis presumed due to Gardnerella vaginalis
Authors: L. M. Nightingale
Journal: JAMA (1986)

CEPHALHEMATOMA is a common condition in the neonate, reported to affect boys more commonly than girls and the right parietal bone more commonly than the left.<sup>1</sup>Neonatal osteomyelitis of the calvaria, on the other hand, is a relatively rare condition.<sup>2-6</sup><i>Gardnerella vaginalis</i>is an organism of low virulence and invasiveness that is associated with nonspecific vaginitis.<sup>7</sup>The following case report describes a patient with cephalhematoma, right parietal osteomyelitis, a scalp aspirate revealing gram-negative pleomorphic rods, and a positive placental culture of gram-negative rods resembling<i>G vaginalis</i>. <h3>Report of a Case</h3> A male infant weighing 4080 g was born at 43 weeks' gestational age to a 17-year-old primigravida after induction of labor with oxytocin. External fetal heart monitoring showed cardiac rhythm irregularity, and accordingly an internal lead (scalp electrode) was inserted into the vertex. The infant was delivered vaginally under local anesthesia by low forceps after a prolonged